Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Tandem Diabetes Care has announced its Tandem t:slim X2 insulin pump is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor. The early access programme for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Tandem t:slim X2 insulin pump can now integrate with ...

Abbott Laboratories has taken a big step in diabetes management by integrating its glucose sensor with a Tandem insulin pump, creating a hybrid closed-loop insulin delivery system. The two companies ...

DUBLIN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market. The G7 ...

For years, Medtronic has trailed behind Dexcom and Abbott in the continuous glucose monitor market. Its newest entry in the space, however, may give its competitors a run for their money. The ...

Continuous glucose monitoring (CGM)-derived metrics reliably identified cystic fibrosis-related diabetes in patients with cystic fibrosis. Additionally, a novel way of analysing CGM data called ...

Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM+, on Tuesday. The trial data ...